BCBA/NXE (BCBA/NXE)

Buenos Aires Stock Exchange: BCBA/NXE · ARS

ARS 14,360

-130.41 (-0.9%)· Recorded snapshot

Market cap	9.2T
Net income (ttm)	-264.5B
EPS (ttm)	-ARS 452
Volume	24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -264.5B
EPS (ttm): -ARS 452
Market cap: 9.2T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-17.7

P25 n/aP50 n/aP75 n/a

ROIC-7.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/NXE indicators

Market & fundamental data

Available fields

144

Groups with data

Currency

CAD

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Canada
Country code	AR
Earnings date	2026-11-04
Employees	142
Employees change	56
Employees growth	72.73%
Enterprise value	ARS 8.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2011
Industry	Uranium
Is primary listing	No
ISIN number	AR0220648593
Last earnings date	2026-03-03
Last refreshed	2026-10-29
Market cap	ARS 9.2T
Next earnings date	2026-11-04
Price	ARS 14,360.00
Price currency	ARS
Sector	Energy
SIC code	1090
Stock price date	2026-10-28
Symbol	bcba/NXE
Website	https://www.nexgenenergy.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.15%
FCF / EV yield	-4.07%
FCF yield	-3.9%
P/B ratio	4.78x
Price / tangible book value	4.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	ARS -1.9B
Profitable quarters	1
ROA	-3.39%
ROA (5Y)	-5.41%
ROCE	-5.96%
ROE	-17.67%
ROE (5Y)	-14.84%
ROIC	-7.64%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth quarters	1
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -300B
Depreciation and amortization	ARS 2.2B
EBIT	ARS -115.2B
EBITDA	ARS -113.2B
EPS	ARS -452.01
Financing cash flow	ARS 1T
Free cash flow	ARS -358.4B
Free cash flow minus SBC	ARS -407.6B
Income taxes	ARS -567.5M
Investing cash flow	ARS -545.2B
Net borrowing	ARS -1.1B
Net cash flow	ARS 401.2B
Net income	ARS -264.5B
Operating cash flow minus SBC	ARS -107.5B
Operating income	ARS -115.2B
Stock-based compensation	ARS 49.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	ARS 2,869.51
Debt / equity	0.34
Interest coverage	-2.58
Long-term assets	ARS 1.5T
Long-term liabilities	ARS -31.1B
Net cash (debt)	ARS 366.3B
Net cash / market cap	3.99%
Net debt / equity	-0.19
Piotroski F-Score	2
Property, plant and equipment	ARS 1.1T
Shareholders' equity	ARS 1.9T
Tangible book value	ARS 1.9T
Tangible book value per share	ARS 2,869.51
Total assets	ARS 2.6T
Total cash	ARS 1T
Total debt	ARS 645.9B
Total liabilities	ARS 713.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	ARS 1.1T
Current liabilities	ARS 744.7B
Current ratio	1.46
Net working capital	ARS -47.3B
Quick ratio	1.44
Working capital	ARS 325.4B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.93%
Shareholder yield	-11.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 16,122.33
1D price change	-0.9%
1M price change	-8.3%
1M total return	-8.3%
1W price change	4.06%
1W total return	4.06%
1Y price change	11.32%
1Y return CAGR	11.33%
1Y total return	11.32%
20-day SMA	ARS 14,100.50
200-day SMA	ARS 16,611.95
3M price change	-4.2%
3M total return	-4.2%
50-day SMA	ARS 15,512.60
50-day SMA vs 200-day SMA	50under200
52-week high	ARS 21,400.00
52-week high date	2026-01-29
52-week low	ARS 11,000.00
52-week low date	2025-11-21
6M price change	-21.49%
6M total return	-21.49%
All-time high	ARS 21,610.00
All-time high date	2025-09-26
All-time low	ARS 4,910.00
All-time low date	2025-04-21
Average true range (ATR)	ARS 720.58
Average volume	174.9
Change from 52-week high	-32.9%
Change from 52-week low	30.55%
Change from all-time high	-33.55%
Change from all-time low	192.46%
Change from open	1.48%
Day's gap	-2.35%
Dollar volume	ARS 344,640
High price	ARS 14,590.00
Low price	ARS 14,110.00
Monthly RSI	52.01
Open price	ARS 14,150.00
Position in 52-week range	52.08%
Previous close	ARS 14,490.00
Price vs 150-day SMA	-10.93%
Price vs 20-day SMA	1.84%
Price vs 200-day SMA	-13.56%
Price vs 50-day SMA	-7.43%
Relative volume	0.14
RSI	48.99
Sharpe ratio	0.41
Sortino ratio	0.71
Volume	24
Weekly RSI	43.86
YTD price change	2.94%
YTD total return	2.94%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	627.1M
Shares change (QoQ)	6.74%
Shares change (YoY)	11.93%
Shares held by insiders	2.21%
Shares held by institutions	53.3%

Deeper analysis on BCBA/NXE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/NXE report

Is a complete BCBA/NXE research report available?

No complete published report is available for bcba/NXE (BCBA/NXE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/NXE (BCBA/NXE)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NXE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NXE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NXE

Frequently asked questions